SCHEMBL19320830

SCHEMBL19320830

COCc1cc(C(=O)O)cc(-c2ccc(F)cc2F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER1 P34995 2/20 0.44
TTR P02766 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MEN1 O00255 1/20 0.44
USP2 O75604 1/20 0.44
ALDH1A1 P00352 1/20 0.44
DHFR P00374 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
LMNA P02545 1/20 0.44
ALB P02768 1/20 0.44
HMGB1 P09429 1/20 0.44
HPGD P15428 1/20 0.44
CXCL12 P48061 1/20 0.44
KMT2A Q03164 1/20 0.44
HIF1A Q16665 1/20 0.44
SLC22A6 Q4U2R8 1/20 0.44
ACMSD Q8TDX5 1/20 0.44
HSD17B10 Q99714 1/20 0.44
AKR1C3 P42330 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19139982 0.88 NPC1 (0.44) KDM4EMEN1LMNAKMT2AAKR1C3
SCHEMBL19325888 0.87 IDO1 (0.45) PTGER1TTRKDM4EMEN1USP2
SCHEMBL475505 0.81 TTR (0.57) PTGER1TTRKDM4EMEN1USP2
SCHEMBL3657877 0.81 AKR1C3 (0.43) PTGER1TTRKDM4EMEN1USP2
SCHEMBL475628 0.80 ALPL (0.51) TTRKDM4EMEN1USP2ALDH1A1
SCHEMBL3656313 0.79 TTR (0.44) PTGER1TTRKDM4EMEN1USP2
SCHEMBL19155483 0.76 ALPL (0.45) TTRKDM4EMEN1LMNAKMT2A
SCHEMBL19140032 0.76 PSEN1 (0.41) KDM4EMEN1LMNAKMT2AAKR1C3
SCHEMBL19320906 0.76 TTR (0.46) PTGER1TTRKDM4EMEN1USP2
SCHEMBL19320904 0.76 MAOB (0.46) PTGER1TTRKDM4EMEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170253607-A1 LONG-ACTING HIV PROTEASE INHIBITOR SHIONOGI & CO., LTD. (JP) 2017-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170253607-A1 LONG-ACTING HIV PROTEASE INHIBITOR CPN1, HAT1, PRSS1 PTGER1 2033/4885TTR 4594/4885KDM4E 1195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.